Mayo Foundation for Medical Education and Research
发明人:
Svetomir N. Markovic,Wendy K. Nevala
申请号：
US16872840
公开号：
US20200268884A1
申请日:
2020.05.12
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This invention relates to antibody-albumin nanoparticle complexes comprising albumin, an antibody with binding specificity for a cancer antigen (e.g. panitumumab), and paclitaxel, wherein the nanoparticle complex has been pre-formed in vitro such that the nanoparticle complex has antigen-binding specificity (e.g. EGFR binding specificity), for the purpose of providing cancer (e.g. EGFR-related cancer) treatments in a subject in need thereof.
